本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Embecta Corp.

11.34
-0.5700-4.79%
盘后11.340.00000.00%17:01 EDT
成交量:42.64万
成交额:490.47万
市值:6.59亿
市盈率:11.45
高:11.94
开:11.80
低:11.23
收:11.91
数据加载中...

公司资料

公司名字:
Embecta Corp.
交易所:
NASDAQ
成立时间:
1924
员工人数:
2100
公司地址:
300 Kimball Drive,Suite 300,Parsippany,New Jersey,United States
邮编:
07054
电话:
传真:
- -
简介:
Embecta Corp.于2021年7月8日在特拉华州成立。该公司是一家全球领先的医疗器械公司,专注于提供解决方案以改善糖尿病患者的健康和福祉。在该公司95年的业务历史中,该公司相信产品已成为世界上糖尿病管理领域最广泛认可和最受尊敬的品牌之一。该公司估计,该公司的产品被100多个国家的近3000万人用于胰岛素和糖尿病的日常管理。该公司拥有广泛的上市产品组合,包括各种笔针、注射器和安全设备,并辅以旨在帮助人们管理糖尿病的专有数字应用程序。

董事

名称
职位
David F. Melcher
Non-Executive Chairman
Devdatt Kurdikar
Director,President and Chief Executive Officer
Carrie L. Anderson
Director
Christopher R. Reidy
Director
Claire Pomeroy
Director
David J. Albritton
Director
Karen N. Prange
Director
Milton M. Morris
Director
Robert J. Hombach
Director

股东

名称
职位
Devdatt Kurdikar
Director,President and Chief Executive Officer
Ajay Kumar
Senior Vice President and Chief Human Resources Officer
Colleen Riley
Senior Vice President and Chief Technology Officer
Ginny Blocki
Senior Vice President, Product Management and Global Marketing
Jacob Elguicze
Senior Vice President and Chief Financial Officer
Jeff Mann
Senior Vice President, General Counsel, Head of Corporate Development, and Corporate Secretary
Shaun Curtis
Senior Vice President, Global Manufacturing and Supply Chain
Slobodan Radumilo
Senior Vice President and President, International
Tom Blount
Senior Vice President and President, North America
Brian Capone
Vice President, Chief Accounting Officer and Corporate Controller